<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <article xmlns="" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
      <head>
         <style type="text/css"> 		 
            	    table {background : #ffffdd;}
            		 	tr {background : #ddddff; padding : 1px;}
            			
         </style>
         <span class="citation_publisher">Hindawi Publishing Corporation</span>
         <h2 class="citation-title">Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell
            Transplantation in Children
         </h2>
         <span class="doi">10.1155/2016/2626081</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Szymon Skoczen</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Miroslaw Bik-Multanowski</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Jacek J. Pietrzyk</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Agnieszka Grabowska</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Kamil Fijorek</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Wojciech Strojny</span>
            <span class="citation_author_institution_ref">4</span>
            <span class="citation_author">Kinga Klus-Kwiecinska</span>
            <span class="citation_author_institution_ref">4</span>
            <span class="citation_author">Walentyna Balwierz</span>
            <span class="citation_author_institution_ref">4</span>
            <span class="citation_author">Maciej Siedlar</span>
            <span class="citation_author_institution_ref">1</span>
         </div>
         <span class="email">[szymon.skoczen@uj.edu.pl]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2016-1-6]</span>
         <span class="citation_copyright">[Copyright 2016: ]</span>
         <span class="citation_licence">[Licence This is an open access article distributed under the Creative Commons Attribution
            License, which permits unrestricted use, distribution, and reproduction in any medium,
            provided the original work is properly cited.]
         </span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>Immune reactions are among the most serious complications observed after hematopoietic
            stem cell transplantation (HSCT) in children. Microarray technique allows for simultaneous
            assessment of expression of nearly all human genes. The objective of the study was
            to compare the whole genome expression in children before and after HSCT. A total
            of 33 children referred for HSCT were enrolled in the study. In 70% of the patients
            HSCT was performed for the treatment of neoplasms. Blood samples were obtained before
            HSCT and six months after the procedure. Subsequently, the whole genome expression
            was assessed in leukocytes using GeneChip Human Gene 1.0 ST microarray. The analysis
            of genomic profiles before and after HSCT revealed altered expression of 124 genes.
            Pathway enrichment analysis revealed upregulation of five pathways after HSCT: allograft
            rejection, graft-versus-host disease, type I diabetes mellitus, autoimmune thyroid
            disease, and viral myocarditis. The activation of those pathways seems to be related
            to immune reactions commonly observed after HSCT. Our results contribute to better
            understanding of the genomic background of the immunologic complications of HSCT.
            
         </p>
      </div>
      <div tagxxx="sec">
         <title>1. Introduction</title>
         <p>Allogeneic hematopoietic stem cell transplantation (HSCT) has progressed from a risky
            experimental therapy to a safe and life-saving treatment modality in a relatively
            short span of five decades [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>]. However, transplant recipients still require prolonged treatment with multiple,
            nonspecific, and toxic immunosuppressive drugs and are at a constant risk of immune
            reactions which may lead to graft-versus-host disease (GvHD) or graft rejection (GR).
            Immune reactions result from the activation of donor lymphocytes with subsequent recognition
            of the host's antigens, emergence of effector T cells, production of alloantibodies,
            and infiltration of tissues by alloreactive cells [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>].
         </p>
         <p>The aim of the study was to analyze the spectrum of alterations of genome expression
            resulting from HSCT.
         </p>
      </div>
      <div tagxxx="sec">
         <title>2. Materials and Methods</title>
         <p>This was a prospective study conducted from May 2009 to September 2012. The study
            group consisted of children and teenagers referred for HSCT, which was performed according
            to disease-specific treatment protocols. The study was approved by the Ethics Committee
            of the Jagiellonian University (KBET/96/B/2008). Written informed consent was obtained
            from all parents and from all patients ≥ 16 years of age.
         </p>
         <div tagxxx="sec">
            <h3>2.1. Microarray Analysis</h3>
            <p>Blood samples (1.5 mL) were collected from each patient before conditioning and approximately
               six months after HSCT (median 6.3 months). We assessed the whole genome expression
               in peripheral blood leukocytes using GeneChip Human Gene 1.0 ST Array (Affymetrix,
               Santa Clara, USA). Total RNA extraction was performed using RiboPure Blood Kit (Ambion,
               Life Technologies, Carlsbad, USA). Whole transcript microarray experiment was performed
               according to the manufacturer's protocol (GeneChip Whole Transcript Sense Target Labeling
               Assay Manual, Version 4).
            </p>
         </div>
         <div tagxxx="sec">
            <h3>2.2. Statistical Analysis</h3>
            <p>Study sample size ensures adequate power to detect a 1.5-fold change. The microarray
               data were preprocessed using the R/Bioconductor package [
               <span ref-type="bibr" rid="B3">
                  <sup>
                     <a href="#B3">3</a>
                  </sup>
               </span>–
               <span ref-type="bibr" rid="B5">
                  <sup>
                     <a href="#B5">5</a>
                  </sup>
               </span>]. Robust Multiarray Average (RMA) was used for normalization [
               <span ref-type="bibr" rid="B6">
                  <sup>
                     <a href="#B6">6</a>
                  </sup>
               </span>]. Quality control was performed by investigating Principal Component Analysis (PCA),
               Relative Log Expression (RLE), and Normalized Unscaled Standard Error (NUSE) plots.
            </p>
            <p>Moderated 
               <i>t</i>-tests [
               <span ref-type="bibr" rid="B7">
                  <sup>
                     <a href="#B7">7</a>
                  </sup>
               </span>] were performed to detect the probes that were differentially expressed between groups,
               using the
               <i> limma</i> package [
               <span ref-type="bibr" rid="B8">
                  <sup>
                     <a href="#B8">8</a>
                  </sup>
               </span>] in the R statistical software. It was assumed that the log
               <sub>2</sub> transformed gene expression levels are normally distributed and the between-group
               variation is of comparable magnitude. Multiple testing correction (Benjamini-Hochberg
               procedure) was applied to control the false discovery rate (FDR) [
               <span ref-type="bibr" rid="B9">
                  <sup>
                     <a href="#B9">9</a>
                  </sup>
               </span>]. Significantly different expression in the probe sets was defined as multiple comparison-corrected
               two-sided 
               <i>p</i> value &lt; 0.05.
            </p>
            <p>DAVID annotation tools were used to compare gene set enrichment between the groups
               [
               <span ref-type="bibr" rid="B10">
                  <sup>
                     <a href="#B10">10</a>
                  </sup>
               </span>, 
               <span ref-type="bibr" rid="B11">
                  <sup>
                     <a href="#B11">11</a>
                  </sup>
               </span>]. The KEGG (Kyoto Encyclopedia of Genes and Genomes; 
               <div tagxxx="ext-link">http://www.genome.jp/kegg/</div>) and Biocarta (
               <div tagxxx="ext-link">http://www.biocarta.com/</div>) pathways were selected for analysis. A set of top 250 differentially expressed genes
               (TOP 250 database) was exported for pathway enrichment analysis.
            </p>
         </div>
      </div>
      <div tagxxx="sec">
         <title>3. Results</title>
         <div tagxxx="sec">
            <h3>3.1. Characteristic of the Study Group</h3>
            <p>The group of patients assessed before HSCT (pre-HSCT group) included 33 patients aged
               1.5–19 (median 10.5) years, referred to the Stem Cell Transplantation Centre of the
               University Children's Hospital in Krakow. The indications for HSCT are listed in 
               <span ref-type="table" rid="tab1">
                  <a href="#tab1">Table 1</a>
               </span>. Characteristics of children referred for HSCT are presented in 
               <span ref-type="table" rid="tab2">
                  <a href="#tab2">Table 2</a>
               </span>.
            </p>
            <p>The group of patients assessed after HSCT (post-HSCT group) included 20 children from
               the pre-HSCT group, aged 2.8–19.5 (median 9.6) years. In six patients in the pre-HSCT
               group the results of the microarray analysis were not reliable for technical reasons
               (poor quality of RNA sample) and another three patients were lost to follow-up. Four
               children died due to complications of treatment or disease progression. All patients
               in the post-HSCT group were treated with ablative conditioning regiments. The key
               clinical characteristics of the post-HSCT group are presented in 
               <span ref-type="table" rid="tab2">
                  <a href="#tab2">Table 2</a>
               </span>.
            </p>
         </div>
         <div tagxxx="sec">
            <h3>3.2. Whole Genome Expression</h3>
            <p>All the primary microarray data were submitted to GEO public repository and are accessible
               using GEO Series accession number GSE69421 (
               <div tagxxx="ext-link">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32472</div>).
            </p>
            <p>A summary of the differentially expressed genes is presented in 
               <span ref-type="table" rid="tab3">
                  <a href="#tab3">Table 3</a>
               </span>.
            </p>
            <p>A comparison of the pre-HSCT group and post-HSCT group revealed 124 genes with difference
               in expression and fold change ≥ 1.5. For 36% of these genes the expression was higher
               in the post-HSCT group (
               <span ref-type="table" rid="tab3">
                  <a href="#tab3">Table 3</a>
               </span>).
            </p>
         </div>
         <div tagxxx="sec">
            <h3>3.3. Pathway Enrichment Analysis</h3>
            <p>Based on the results presented in 
               <span ref-type="table" rid="tab4">
                  <a href="#tab4">Table 4</a>
               </span>, pathway enrichment analysis was performed.
            </p>
            <p>The genes showing overexpression in the post-HSCT group compared with the pre-HSCT
               group formed pathways responsible for donor/recipient alloaggression, including “allograft
               rejection” and “graft-versus-host disease,” which represent the most common complications
               of HSCT as well as pathways representing immunologic reaction against specific organs
               (“type I diabetes mellitus,” “autoimmune thyroid disease,” and “viral myocarditis”),
               which are among the late complications of HSCT. At the same time parallel activation
               of genes forming “antigen processing and presentation” pathway was observed.
            </p>
            <p>The genes showing underexpression in the post-HSCT group compared with the pre-HSCT
               group represent pathways regulating erythropoiesis and metabolism of proteins. As
               analysis was performed after intensive proliferation due to reconstitution of hematopoiesis,
               inhibition of these genes might have occurred. The pathway “Th1/Th2 Differentiation”
               could be inhibited as a result of prolonged immunosuppressive treatment used for GvHD
               prevention in most patients treated with HSCT.
            </p>
         </div>
      </div>
      <div tagxxx="sec">
         <title>4. Discussion</title>
         <p>Acute graft-versus-host disease (aGvHD) is the leading cause of morbidity and mortality
            after HSCT that affects the skin, liver, and gastrointestinal tract and contributes
            to transplant-related morbidity and mortality [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>]. Approximately 50% of patients treated with HSCT subsequently develop aGvHD and
            require systemic treatment [
            <span ref-type="bibr" rid="B12">
               <sup>
                  <a href="#B12">12</a>
               </sup>
            </span>]. Chronic graft-versus-host disease (cGvHD) occurs in 40% of patients treated with
            HSCT from an HLA-identical sibling and in more than 50% of patients treated with HSCT
            from an HLA-nonidentical related donor and in 70% of patients treated with HSCT from
            an HLA-matched unrelated donor. The onset of symptoms is within a median of 133 days
            after an unrelated donor HSCT [
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">13</a>
               </sup>
            </span>]. cGvHD is an immunoregulatory disorder occurring after allogeneic HSCT and has clinical
            features of both autoimmune disorder and immunodeficiency. The features of cGvHD resemble
            other autoimmune diseases such as Sjögren syndrome, scleroderma, primary biliary cirrhosis,
            and immune cytopenia [
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">14</a>
               </sup>
            </span>]. Graft rejection (GR) occurs in 12% of children undergoing allogeneic HSCT within
            a median of 63 days after the transplantation [
            <span ref-type="bibr" rid="B15">
               <sup>
                  <a href="#B15">15</a>
               </sup>
            </span>]. Our study revealed that the genes showing overexpression in the post-HSCT group
            compared with the pre-HSCT group formed the pathways responsible for “allograft rejection”
            and “graft-versus-host disease” thus giving genetic background for the observed immune
            reactions. Even though no case of GR was observed in the study group, the activation
            of the genes responsible for GR is obvious, and our results suggest the effectiveness
            of the preventive treatment used in these patients.
         </p>
         <p>The microarray analysis indicated presence of three other pathways: “type I diabetes
            mellitus,” “autoimmune thyroid disease,” and “viral myocarditis.” The incidence of
            compensated hypothyroidism in patients after HSCT ranges from 25 to 30% with a median
            latency of 2 years; overt hypothyroidism is diagnosed in up to 9% of patients with
            a latency of 2.7 years. Younger age is associated with higher risk of hypothyroidism
            [
            <span ref-type="bibr" rid="B16">
               <sup>
                  <a href="#B16">16</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">17</a>
               </sup>
            </span>]. Patients treated with HSCT also have 2.3- to 4.0-fold higher risk of death due
            to cardiac causes compared with the general population [
            <span ref-type="bibr" rid="B18">
               <sup>
                  <a href="#B18">18</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">19</a>
               </sup>
            </span>]. The cumulative incidence of cardiovascular diseases approaches 23% at 25 years
            after HSCT and is highest among the allogeneic HSCT recipients. The incidence appears
            to increase with time [
            <span ref-type="bibr" rid="B20">
               <sup>
                  <a href="#B20">20</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">21</a>
               </sup>
            </span>]. Moreover, the patients treated with HSCT are known to have an increased risk of
            diabetes mellitus [
            <span ref-type="bibr" rid="B22">
               <sup>
                  <a href="#B22">22</a>
               </sup>
            </span>]. The risk of diabetes adjusted for age, sex, race, and BMI is 3.7 times higher in
            patients after allogeneic HSCT compared with the general population [
            <span ref-type="bibr" rid="B23">
               <sup>
                  <a href="#B23">23</a>
               </sup>
            </span>].
         </p>
         <p>Activated T cells play additional important role in controlling a variety of critical
            steps after HSCT, such as facilitating engraftment of hematopoietic stem cells, immune
            reconstitution, and elimination of residual disease, but they are also responsible
            for immune reactions against the host's tissues [
            <span ref-type="bibr" rid="B24">
               <sup>
                  <a href="#B24">24</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B25">
               <sup>
                  <a href="#B25">25</a>
               </sup>
            </span>]. Our data support the hypothesis on the role of activation of gene machinery resulting
            in aggression of donor immune system against specific host organs leading to deterioration
            of their function. Regulatory T cells have been shown to mitigate immune reactions
            after HSCT by suppressing the early expansion of donor T cells [
            <span ref-type="bibr" rid="B26">
               <sup>
                  <a href="#B26">26</a>
               </sup>
            </span>].
         </p>
         <p>So far, there is no validated diagnostic or predictive blood biomarker for GvHD which
            could improve diagnosis and prognosis and help to guide therapeutic interventions
            [
            <span ref-type="bibr" rid="B26">
               <sup>
                  <a href="#B26">26</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B27">
               <sup>
                  <a href="#B27">27</a>
               </sup>
            </span>]. Currently, the diagnosis of GvHD is based on clinical manifestations in one or
            more of the main target organs and on biopsy results. Moreover, once GvHD occurs,
            the most important predictor of long-term survival is the primary response to therapy.
            In patients who are resistant to initial therapy, the risk of morbidity and mortality
            increases significantly [
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">28</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B29">
               <sup>
                  <a href="#B29">29</a>
               </sup>
            </span>]. Thus, there is a need to identify new biomarkers to predict not only GvHD development
            but also the survival and treatment outcomes of GvHD. Future studies might answer
            the question whether specific gene expression patterns can be used as biomarkers of
            immune complications after HSCT.
         </p>
         <p>In conclusion, the results of our whole genome expression study revealed altered expression
            of the genes responsible for immune reactions against recipient/donor cells, proving
            genetic background for one of the most common complications (GvHD, GR), observed after
            HSCT.
         </p>
      </div>
      <back>
         <div tagxxx="ack">
            <title>Acknowledgment</title>
            <p>This work was supported by national Grant no. NN 407 198737.</p>
         </div>
         <div tagxxx="sec">
            <title>Conflict of Interests</title>
            <p>The authors declare that there is no conflict of interests regarding the publication
               of this paper.
            </p>
         </div>
         <div tagxxx="sec">
            <title>Authors' Contribution</title>
            <p>Szymon Skoczen designed and performed research, analyzed and interpreted data, and
               wrote the paper. Miroslaw Bik-Multanowski performed research and analyzed and interpreted
               data. Agnieszka Grabowska and Kamil Fijorek performed research and collected data.
               Wojciech Strojny and Kinga Klus-Kwiecinska analyzed and interpreted data. Jacek J.
               Pietrzyk, Walentyna Balwierz, and Maciej Siedlar conducted the clinical protocols
               and interpreted data.
            </p>
         </div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B1"></a>
                  <label>1</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Thomas</span>
                           <span tagx="given-names">E. D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lochate</span>
                           <span tagx="given-names">H. L.</span>
                           <div tagxxx="suffix">Jr.</div>
                        </name>
                        <name>
                           <span tagx="surname">Lu</span>
                           <span tagx="given-names">W. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ferrebee</span>
                           <span tagx="given-names">J. W.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy</span>
                     <span tagx="source">
                        <i>The New England Journal of Medicine</i>
                     </span>
                     <span tagx="year">1957</span>
                     <span tagx="volume">257</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">491</span>
                     <span tagx="lpage">496</span>
                     <span class="pub-id'">[10.1056/nejm195709122571102]</span>
                     <span class="pub-id'">[2-s2.0-0000970496]</span>
                     <span class="pub-id'">[13464965]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <label>2</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ferrara</span>
                           <span tagx="given-names">J. L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Levine</span>
                           <span tagx="given-names">J. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Reddy</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Holler</span>
                           <span tagx="given-names">E.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Graft-versus-host disease</span>
                     <span tagx="source">
                        <i>The Lancet</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">373</span>
                     <div tagxxx="issue">9674</div>
                     <span tagx="fpage">1550</span>
                     <span tagx="lpage">1561</span>
                     <span class="pub-id'">[10.1016/s0140-6736(09)60237-3]</span>
                     <span class="pub-id'">[2-s2.0-65349171937]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <label>3</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">M. T.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Power and sample size considerations</span>
                     <span tagx="source">
                        <i>Analysis of Microarray Expression Data</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span class="publisher-loc'">[Boston, Mass, USA]</span>
                     <span class="publisher-name'">[Kluwer Academic Publishers]</span>
                     <span tagx="fpage">191</span>
                     <span tagx="lpage">236</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <label>4</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gentleman</span>
                           <span tagx="given-names">R. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Carey</span>
                           <span tagx="given-names">V. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Bates</span>
                           <span tagx="given-names">D. M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Bioconductor: open software development for computational biology and bioinformatics</span>
                     <span tagx="source">
                        <i>Genome Biology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">5</span>
                     <div tagxxx="issue">10, article R80</div>
                     <span class="pub-id'">[10.1186/gb-2004-5-10-r80]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <label>5</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Bengtsson</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Simpson</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Bullard</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hansen</span>
                           <span tagx="given-names">K.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Aroma.affymetrix: a generic framework in R for analyzing small to very large Affymetrix
                        data sets in bounded memory
                     </span>
                     <span tagx="year">2004</span>
                     <div tagxxx="issue">745</div>
                     <span class="publisher-loc'">[Berkeley, Calif, USA]</span>
                     <span class="publisher-name'">[Department of Statistics, University of California]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <label>6</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Irizarry</span>
                           <span tagx="given-names">R. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hobbs</span>
                           <span tagx="given-names">B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Collin</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Exploration, normalization, and summaries of high density oligonucleotide array probe
                        level data
                     </span>
                     <span tagx="source">
                        <i>Biostatistics</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">4</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">249</span>
                     <span tagx="lpage">264</span>
                     <span class="pub-id'">[10.1093/biostatistics/4.2.249]</span>
                     <span class="pub-id'">[2-s2.0-0142121516]</span>
                     <span class="pub-id'">[12925520]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <label>7</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Smyth</span>
                           <span tagx="given-names">G. K.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Linear models and empirical Bayes methods for assessing differential expression in
                        microarray experiments
                     </span>
                     <span tagx="source">
                        <i>Statistical Applications in Genetics and Molecular Biology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">3</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">1</span>
                     <span tagx="lpage">25</span>
                     <span class="pub-id'">[10.2202/1544-6115.1027]</span>
                     <span class="pub-id'">[MR2101454]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <label>8</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Smyth</span>
                           <span tagx="given-names">G. K.</span>
                        </name>
                     </span>
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gentleman</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Carey</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <name>
                           <span tagx="surname">Dudoit</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Irizarry</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Huber</span>
                           <span tagx="given-names">W.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Limma: linear models for microarray data</span>
                     <span tagx="source">
                        <i>Bioinformatics and Computational Biology Solutions Using R and Bioconductor</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span class="publisher-loc'">[New York, NY, USA]</span>
                     <span class="publisher-name'">[Springer]</span>
                     <span tagx="fpage">397</span>
                     <span tagx="lpage">420</span>
                     <div tagxxx="series">Statistics for Biology and Health</div>
                     <span class="pub-id'">[10.1007/0-387-29362-0_23]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <label>9</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Benjamini</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hochberg</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Controlling the false discovery rate: a practical and powerful approach to multiple
                        testing
                     </span>
                     <span tagx="source">
                        <i>Journal of the Royal Statistical Society: Series B (Statistical Methodology)</i>
                     </span>
                     <span tagx="year">1995</span>
                     <span tagx="volume">57</span>
                     <span tagx="fpage">289</span>
                     <span tagx="lpage">300</span>
                     <span class="pub-id'">[Zbl0809.62014]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <label>10</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Huang</span>
                           <span tagx="given-names">D. W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sherman</span>
                           <span tagx="given-names">B. T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lempicki</span>
                           <span tagx="given-names">R. A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Systematic and integrative analysis of large gene lists using DAVID bioinformatics
                        resources
                     </span>
                     <span tagx="source">
                        <i>Nature Protocols</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">4</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">44</span>
                     <span tagx="lpage">57</span>
                     <span class="pub-id'">[10.1038/nprot.2008.211]</span>
                     <span class="pub-id'">[2-s2.0-61449172037]</span>
                     <span class="pub-id'">[19131956]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <label>11</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Huang</span>
                           <span tagx="given-names">D. W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sherman</span>
                           <span tagx="given-names">B. T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lempicki</span>
                           <span tagx="given-names">R. A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Bioinformatics enrichment tools: paths toward the comprehensive functional analysis
                        of large gene lists
                     </span>
                     <span tagx="source">
                        <i>Nucleic Acids Research</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">37</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">1</span>
                     <span tagx="lpage">13</span>
                     <span class="pub-id'">[10.1093/nar/gkn923]</span>
                     <span class="pub-id'">[2-s2.0-58549112996]</span>
                     <span class="pub-id'">[19033363]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <label>12</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Blazar</span>
                           <span tagx="given-names">B. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Murphy</span>
                           <span tagx="given-names">W. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Abedi</span>
                           <span tagx="given-names">M.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Advances in graft-versus-host disease biology and therapy</span>
                     <span tagx="source">
                        <i>Nature Reviews Immunology</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">12</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">443</span>
                     <span tagx="lpage">458</span>
                     <span class="pub-id'">[10.1038/nri3212]</span>
                     <span class="pub-id'">[2-s2.0-84861576998]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <label>13</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Sullivan</span>
                           <span tagx="given-names">K. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Agura</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Anasetti</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Chronic graft-versus-host disease and other late complications of bone marrow transplantation</span>
                     <span tagx="source">
                        <i>Seminars in Hematology</i>
                     </span>
                     <span tagx="year">1991</span>
                     <span tagx="volume">28</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">250</span>
                     <span tagx="lpage">259</span>
                     <span class="pub-id'">[2-s2.0-0025860239]</span>
                     <span class="pub-id'">[1887253]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <label>14</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Shimabukuro-Vornhagen</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hallek</span>
                           <span tagx="given-names">M. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Storb</span>
                           <span tagx="given-names">R. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">von Bergwelt-Baildon</span>
                           <span tagx="given-names">M. S.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The role of B cells in the pathogenesis of graft-versus-host disease</span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">114</span>
                     <div tagxxx="issue">24</div>
                     <span tagx="fpage">4919</span>
                     <span tagx="lpage">4927</span>
                     <span class="pub-id'">[10.1182/blood-2008-10-161638]</span>
                     <span class="pub-id'">[2-s2.0-73949093279]</span>
                     <span class="pub-id'">[19749094]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <label>15</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Breuer</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Preuner</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Fritsch</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment
                        of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation
                     </span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">26</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">509</span>
                     <span tagx="lpage">519</span>
                     <span class="pub-id'">[10.1038/leu.2011.244]</span>
                     <span class="pub-id'">[2-s2.0-84857997026]</span>
                     <span class="pub-id'">[21926962]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <label>16</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Berger</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Le-Gallo</span>
                           <span tagx="given-names">B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Donadieu</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation
                        for acute lymphoblastic leukaemia
                     </span>
                     <span tagx="source">
                        <i>Bone Marrow Transplantation</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">35</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">991</span>
                     <span tagx="lpage">995</span>
                     <span class="pub-id'">[10.1038/sj.bmt.1704945]</span>
                     <span class="pub-id'">[2-s2.0-21044455289]</span>
                     <span class="pub-id'">[15806126]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B17"></a>
                  <label>17</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ishiguro</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Yasuda</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tomita</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Long-term follow-up of thyroid function in patients who received bone marrow transplantation
                        during childhood and adolescence
                     </span>
                     <span tagx="source">
                        <i>The Journal of Clinical Endocrinology &amp; Metabolism</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">89</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">5981</span>
                     <span tagx="lpage">5986</span>
                     <span class="pub-id'">[10.1210/jc.2004-0836]</span>
                     <span class="pub-id'">[2-s2.0-10344248700]</span>
                     <span class="pub-id'">[15579747]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B18"></a>
                  <label>18</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Bhatia</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Francisco</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Carter</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Late mortality after allogeneic hematopoietic cell transplantation and functional
                        status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">110</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">3784</span>
                     <span tagx="lpage">3792</span>
                     <span class="pub-id'">[10.1182/blood-2007-03-082933]</span>
                     <span class="pub-id'">[2-s2.0-36348990261]</span>
                     <span class="pub-id'">[17671231]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B19"></a>
                  <label>19</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Majhail</span>
                           <span tagx="given-names">N. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ness</span>
                           <span tagx="given-names">K. K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Burns</span>
                           <span tagx="given-names">L. J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous
                        hematopoietic cell transplantation: a report from the bone marrow transplant survivor
                        study
                     </span>
                     <span tagx="source">
                        <i>Biology of Blood and Marrow Transplantation</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">13</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">1153</span>
                     <span tagx="lpage">1159</span>
                     <span class="pub-id'">[10.1016/j.bbmt.2007.06.003]</span>
                     <span class="pub-id'">[2-s2.0-34548671197]</span>
                     <span class="pub-id'">[17889351]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B20"></a>
                  <label>20</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Wilson</span>
                           <span tagx="given-names">P. W. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">D'Agostino</span>
                           <span tagx="given-names">R. B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Levy</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Belanger</span>
                           <span tagx="given-names">A. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Silbershatz</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kannel</span>
                           <span tagx="given-names">W. B.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Prediction of coronary heart disease using risk factor categories</span>
                     <span tagx="source">
                        <i>Circulation</i>
                     </span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">97</span>
                     <div tagxxx="issue">18</div>
                     <span tagx="fpage">1837</span>
                     <span tagx="lpage">1847</span>
                     <span class="pub-id'">[10.1161/01.cir.97.18.1837]</span>
                     <span class="pub-id'">[2-s2.0-0032510639]</span>
                     <span class="pub-id'">[9603539]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B21"></a>
                  <label>21</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Grundy</span>
                           <span tagx="given-names">S. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pasternak</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Greenland</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">S.</span>
                           <div tagxxx="suffix">Jr.</div>
                        </name>
                        <name>
                           <span tagx="surname">Fuster</span>
                           <span tagx="given-names">V.</span>
                        </name>
                     </span>
                     <span tagx="article-title">AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor
                        assessment equations: a statement for healthcare professionals from the American Heart
                        Association and the American College of Cardiology
                     </span>
                     <span tagx="source">
                        <i>Journal of the American College of Cardiology</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">34</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">1348</span>
                     <span tagx="lpage">1359</span>
                     <span class="pub-id'">[10.1016/s0735-1097(99)00387-3]</span>
                     <span class="pub-id'">[2-s2.0-0033210739]</span>
                     <span class="pub-id'">[10520820]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B22"></a>
                  <label>22</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Bhatia</span>
                           <span tagx="given-names">S.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Long-term health impacts of hematopoietic stem cell transplantation in form recommendations
                        for follow-up
                     </span>
                     <span tagx="source">
                        <i>Expert Review of Hematology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">4</span>
                     <span tagx="fpage">437</span>
                     <span tagx="lpage">452</span>
                     <span class="pub-id'">[21801135]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B23"></a>
                  <label>23</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Baker</span>
                           <span tagx="given-names">K. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ness</span>
                           <span tagx="given-names">K. K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Steinberger</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell
                        transplantation: a report from the bone marrow transplantation survivor study
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">109</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">1765</span>
                     <span tagx="lpage">1772</span>
                     <span class="pub-id'">[10.1182/blood-2006-05-022335]</span>
                     <span class="pub-id'">[2-s2.0-33846925492]</span>
                     <span class="pub-id'">[17047152]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B24"></a>
                  <label>24</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Curtis</span>
                           <span tagx="given-names">R. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Travis</span>
                           <span tagx="given-names">L. B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rowlings</span>
                           <span tagx="given-names">P. A.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional
                        study
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">94</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">2208</span>
                     <span tagx="lpage">2216</span>
                     <span class="pub-id'">[2-s2.0-0033214901]</span>
                     <span class="pub-id'">[10498590]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B25"></a>
                  <label>25</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ayuk</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Shimoni</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Nagler</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after
                        reduced intensity conditioning allograft for multiple myeloma
                     </span>
                     <span tagx="source">
                        <i>Leukemia</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">18</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">659</span>
                     <span tagx="lpage">662</span>
                     <span class="pub-id'">[10.1038/sj.leu.2403252]</span>
                     <span class="pub-id'">[2-s2.0-1542608518]</span>
                     <span class="pub-id'">[14671630]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B26"></a>
                  <label>26</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Edinger</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hoffmann</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ermann</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">CD4
                        <sup>+</sup>CD25
                        <sup>+</sup> regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host
                        disease after bone marrow transplantation
                     </span>
                     <span tagx="source">
                        <i>Nature Medicine</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">9</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">1144</span>
                     <span tagx="lpage">1150</span>
                     <span class="pub-id'">[10.1038/nm915]</span>
                     <span class="pub-id'">[2-s2.0-0141461418]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B27"></a>
                  <label>27</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Paczesny</span>
                           <span tagx="given-names">S.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Discovery and validation of graft versus-host disease biomarkers</span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">121</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">585</span>
                     <span tagx="lpage">594</span>
                     <span class="pub-id'">[10.1182/blood-2012-08-355990]</span>
                     <span class="pub-id'">[2-s2.0-84873044177]</span>
                     <span class="pub-id'">[23165480]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B28"></a>
                  <label>28</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Van Lint</span>
                           <span tagx="given-names">M. T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Milone</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Leotta</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Treatment of acute graft-versus-host disease with prednisolone: significant survival
                        advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte
                        globulin
                     </span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">107</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">4177</span>
                     <span tagx="lpage">4181</span>
                     <span class="pub-id'">[10.1182/blood-2005-12-4851]</span>
                     <span class="pub-id'">[2-s2.0-33646548277]</span>
                     <span class="pub-id'">[16449522]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B29"></a>
                  <label>29</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Deeg</span>
                           <span tagx="given-names">H. J.</span>
                        </name>
                     </span>
                     <span tagx="article-title">How I treat refractory acute GVHD</span>
                     <span tagx="source">
                        <i>Blood</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">109</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">4119</span>
                     <span tagx="lpage">4126</span>
                     <span class="pub-id'">[10.1182/blood-2006-12-041889]</span>
                     <span class="pub-id'">[2-s2.0-34248356010]</span>
                     <span class="pub-id'">[17234737]</span>
                  </span>
               </li>
            </ul>
         </div>
      </back>
      <div tagxxx="floats-group">
         <div id="tab1">
            <label>Table 1</label>
            <caption>
               <p>The indications for HSCT (pre-HSCT group).</p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th>Condition</th>
                     <th>
                        <i>n</i> (%)
                     </th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Acute lymphoblastic leukemia (ALL)</td>
                     <td>15 (36)</td>
                  </tr>
                  <tr>
                     <td>Acute myeloblastic leukemia (AML)</td>
                     <td>5 (15)</td>
                  </tr>
                  <tr>
                     <td>Acute bilineage leukemia (ABL)</td>
                     <td>1 (3)</td>
                  </tr>
                  <tr>
                     <td>Juvenile myelomonocytic and acute myeloblastic leukemia (JMML/AML)</td>
                     <td>1 (3)</td>
                  </tr>
                  <tr>
                     <td>Myelodysplastic syndrome (MDS)</td>
                     <td>1 (3)</td>
                  </tr>
                  <tr>
                     <td>
                        <b>Neoplasms (total)</b>
                     </td>
                     <td>
                        <b>23 (70)</b>
                     </td>
                  </tr>
                  <tr>
                     <td>Severe aplastic anemia (SAA)</td>
                     <td>4 (12)</td>
                  </tr>
                  <tr>
                     <td>Chronic granulomatous disease (CGD)</td>
                     <td>3 (9)</td>
                  </tr>
                  <tr>
                     <td>Autoimmune lymphoproliferative syndrome (ALPS)</td>
                     <td>1 (3)</td>
                  </tr>
                  <tr>
                     <td>Hyper-IgM syndrome (HIgM)</td>
                     <td>1 (3)</td>
                  </tr>
                  <tr>
                     <td>Inherited neutropenia (IN)</td>
                     <td>1 (3)</td>
                  </tr>
                  <tr>
                     <td>
                        <b>Nonneoplastic conditions (total)</b>
                     </td>
                     <td>
                        <b>10 (30)</b>
                     </td>
                  </tr>
               </tbody>
            </table>
         </div>
         <div id="tab2">
            <label>Table 2</label>
            <caption>
               <p>Characteristics of studied groups.</p>
            </caption>
            <table>
               <tbody>
                  <tr>
                     <td>Pre-HSCT group</td>
                  </tr>
                  <tr>
                     <td>
                        <i>N</i>
                     </td>
                     <td>33</td>
                  </tr>
                  <tr>
                     <td>Sex</td>
                     <td>Boys 25, girls 8</td>
                  </tr>
                  <tr>
                     <td>Age (years)</td>
                     <td>1.5–19 (median 10.5)</td>
                  </tr>
                  <tr>
                     <td>Chemotherapy before HSCT (%)</td>
                     <td>23 (71%)</td>
                  </tr>
                  <tr>
                     <td> First line</td>
                     <td>13</td>
                  </tr>
                  <tr>
                     <td> Second line</td>
                     <td>9</td>
                  </tr>
                  <tr>
                     <td> ≥third line</td>
                     <td>1</td>
                  </tr>
                  <tr>
                     <td>Local radiotherapy</td>
                     <td>7</td>
                  </tr>
                  <tr>
                     <td>Cranial (dose)</td>
                     <td>5 (12 Gy-4, 18 Gy-1)</td>
                  </tr>
                  <tr>
                     <td>Testes (dose)</td>
                     <td>2 (12 Gy/24 Gy, 18 Gy/18 Gy)</td>
                  </tr>
                  <tr>
                     <td>Time since diagnosis and patient selection (years)</td>
                     <td>Median, 1.4; range 0.08–12.9</td>
                  </tr>
                  <tr>
                     <td>
                        <hr></hr>
                     </td>
                  </tr>
                  <tr>
                     <td>Post-HSCT group</td>
                  </tr>
                  <tr>
                     <td>
                        <i>N</i>
                     </td>
                     <td>20</td>
                  </tr>
                  <tr>
                     <td>Sex</td>
                     <td>Boys 14, girls 7</td>
                  </tr>
                  <tr>
                     <td>Age (years)</td>
                     <td>2.8–19.5 (median 9.6)</td>
                  </tr>
                  <tr>
                     <td>Conditioning regimen based on busulfan (
                        <i>n</i>)
                     </td>
                     <td>9 (45%)</td>
                  </tr>
                  <tr>
                     <td>Total body irradiation, 12 Gy/6 fractions (
                        <i>n</i>)
                     </td>
                     <td>6 (30%)</td>
                  </tr>
                  <tr>
                     <td>GvHD prophylaxis (
                        <i>n</i>)
                     </td>
                     <td> </td>
                  </tr>
                  <tr>
                     <td> Ciclosporin</td>
                     <td>2 (10%)</td>
                  </tr>
                  <tr>
                     <td> Methotrexate + ciclosporin</td>
                     <td>18 (90%)</td>
                  </tr>
                  <tr>
                     <td>GvHD (
                        <i>n</i>)
                     </td>
                     <td>14 (70%)</td>
                  </tr>
                  <tr>
                     <td>Median time from HSCT to the second assessment (range)</td>
                     <td>6.4 (6–13) months</td>
                  </tr>
                  <tr>
                     <td>Systemic glucocorticoids (%)</td>
                     <td>16 (80%)</td>
                  </tr>
                  <tr>
                     <td>Median and range of cumulative dose of glucocorticoids (equivalent of prednisone)</td>
                     <td>1463 (29–9758) mg/m
                        <sup>2</sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Median duration of systemic glucocorticoids therapy</td>
                     <td>105 (3–240) days</td>
                  </tr>
                  <tr>
                     <td>Median time since discontinuation of glucocorticoids (range)</td>
                     <td>3.5 (0.4–14.3) months</td>
                  </tr>
                  <tr>
                     <td>Median time from discontinuation of immunosuppressive treatment to the second assessment
                        (range) (16 patients)
                     </td>
                     <td>1.8 (0–9) months</td>
                  </tr>
               </tbody>
            </table>
         </div>
         <div id="tab3">
            <label>Table 3</label>
            <caption>
               <p>Summary of the number of differentially expressed genes between studied groups.</p>
            </caption>
            <table>
               <tbody>
                  <tr>
                     <td>Study groups</td>
                     <td>Genes with significant differences revealed after Benjamini-Hochberg correction</td>
                     <td>Number of genes with expression fold change ≥ 1.5</td>
                  </tr>
                  <tr>
                     <td>+1.5</td>
                     <td>−1.5</td>
                  </tr>
                  <tr>
                     <td>
                        <hr></hr>
                     </td>
                  </tr>
                  <tr>
                     <td>Post-HSCT/pre-HSCT</td>
                     <td>13
                        <div tagxxx="break"></div>Fold change
                        <div tagxxx="break"></div>+1.5–0
                        <div tagxxx="break"></div>−1.5–1
                     </td>
                     <td>44</td>
                     <td>80</td>
                  </tr>
               </tbody>
            </table>
         </div>
         <div id="tab4">
            <label>Table 4</label>
            <caption>
               <p>Summary of the pathway analysis for the differentially expressed genes from TOP 250
                  database between the post-HSCT and pre-HSCT group.
               </p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th>Fold change 
                        <div tagxxx="break"></div>Number of exported genes
                     </th>
                     <th>Name of pathway map</th>
                     <th>Number of pathway maps </th>
                     <th>Published by</th>
                     <th>Participating genes (%) </th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Whole list
                        <div tagxxx="break"></div>250
                        <div tagxxx="break"></div>Underexpressed
                     </td>
                     <td>Ribosome</td>
                     <td>hsa03010</td>
                     <td>KEGG_PATHWAY</td>
                     <td>26.5</td>
                  </tr>
                  <tr>
                     <td>Porphyrin and chlorophyll metabolism</td>
                     <td>hsa00860</td>
                  </tr>
                  <tr>
                     <td>Primary immunodeficiency</td>
                     <td>hsa05340</td>
                  </tr>
                  <tr>
                     <td>Hematopoietic cell lineage</td>
                     <td>hsa05213</td>
                  </tr>
                  <tr>
                     <td>Aldosterone-regulated sodium reabsorption</td>
                     <td>hsa04960</td>
                  </tr>
                  <tr>
                     <td>Hemoglobin Chaperone</td>
                     <td>h_ahsp</td>
                     <td>BIOCARTA</td>
                     <td>10.3</td>
                  </tr>
                  <tr>
                     <td>Th1/Th2 Differentiation</td>
                     <td>h_th1th2</td>
                  </tr>
                  <tr>
                     <td>3′-UTR-mediated translational regulation</td>
                     <td>REACT_1762</td>
                     <td>REACTOME_PATHWAY</td>
                     <td>17.6</td>
                  </tr>
                  <tr>
                     <td>Influenza infection</td>
                     <td>REACT_6167</td>
                  </tr>
                  <tr>
                     <td>Metabolism of proteins</td>
                     <td>REACT_17015</td>
                  </tr>
                  <tr>
                     <td>Metabolism of porphyrins</td>
                     <td>REACT_9431</td>
                  </tr>
                  <tr>
                     <td>Gene expression</td>
                     <td>REACT_71</td>
                  </tr>
                  <tr>
                     <td>
                        <hr></hr>
                     </td>
                  </tr>
                  <tr>
                     <td>Whole list
                        <div tagxxx="break"></div>250
                        <div tagxxx="break"></div>Overexpressed
                     </td>
                     <td>Type I diabetes mellitus</td>
                     <td>hsa04940</td>
                     <td>KEGG_PATHWAY</td>
                     <td>20.8</td>
                  </tr>
                  <tr>
                     <td>Allograft rejection</td>
                     <td>hsa05330</td>
                  </tr>
                  <tr>
                     <td>Graft-versus-host disease</td>
                     <td>hsa05332</td>
                  </tr>
                  <tr>
                     <td>Autoimmune thyroid disease</td>
                     <td>hsa05320</td>
                  </tr>
                  <tr>
                     <td>Viral myocarditis</td>
                     <td>hsa05416</td>
                  </tr>
                  <tr>
                     <td>Hematopoietic cell lineage</td>
                     <td>hsa05213</td>
                  </tr>
                  <tr>
                     <td>Antigen processing and presentation</td>
                     <td>hsa04612</td>
                  </tr>
                  <tr>
                     <td>Natural killer-cell mediated cytotoxicity</td>
                     <td>hsa04650</td>
                  </tr>
                  <tr>
                     <td>B-cell receptor signaling pathway</td>
                     <td>hsa04662</td>
                  </tr>
                  <tr>
                     <td>Primary immunodeficiency</td>
                     <td>hsa05340</td>
                  </tr>
                  <tr>
                     <td>Neuroactive ligand-receptor interaction</td>
                     <td>hsa04080</td>
                  </tr>
                  <tr>
                     <td>Cytokine-cytokine receptor interaction</td>
                     <td>hsa04060</td>
                  </tr>
                  <tr>
                     <td>Signaling of immune system</td>
                     <td>REACT_6900</td>
                     <td>REACTOME_PATHWAY</td>
                     <td>15.3</td>
                  </tr>
                  <tr>
                     <td>CTCF</td>
                     <td>h_ctcf</td>
                     <td>BIOCARTA </td>
                     <td>8.8</td>
                  </tr>
                  <tr>
                     <td>B-cell receptor complex</td>
                     <td>h_bcr</td>
                  </tr>
                  <tr>
                     <td>Inflammation mediated by chemokine and cytokine pathway</td>
                     <td>P0003</td>
                     <td>PANTHER_PATHWAY</td>
                     <td>12</td>
                  </tr>
                  <tr>
                     <td>B-cell activation</td>
                     <td>P00010</td>
                  </tr>
                  <tr>
                     <td>
                        <hr></hr>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        ≥1.5 
                        <div tagxxx="break"></div>44
                     </td>
                     <td>Hematopoietic cell lineage</td>
                     <td>hsa05320</td>
                     <td>KEGG_PATHWAY</td>
                     <td>19.5</td>
                  </tr>
                  <tr>
                     <td>Epithelial cell signaling in 
                        <i>Helicobacter pylori</i> infection
                     </td>
                     <td>hsa05120</td>
                  </tr>
                  <tr>
                     <td>B-cell activation</td>
                     <td>P00010</td>
                     <td>PANTHER_PATHWAY</td>
                     <td>12.2</td>
                  </tr>
                  <tr>
                     <td>
                        <hr></hr>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        ≤−1.5 
                        <div tagxxx="break"></div>80
                     </td>
                     <td>Porphyrin and chlorophyll metabolism</td>
                     <td>hsa00860</td>
                     <td>KEGG_PATHWAY</td>
                     <td>32.3</td>
                  </tr>
                  <tr>
                     <td>Hemoglobin Chaperone</td>
                     <td>h_ahsp</td>
                     <td>BIOCARTA</td>
                     <td>16.1</td>
                  </tr>
                  <tr>
                     <td>Heme biosynthesis</td>
                     <td>P02976</td>
                     <td>PANTHER_PATHWAY</td>
                     <td>14.5</td>
                  </tr>
                  <tr>
                     <td>Metabolism of porphyrins</td>
                     <td>REACT_9431</td>
                     <td>REACTOME_PATHWAY</td>
                     <td>21</td>
                  </tr>
               </tbody>
            </table>
         </div>
      </div>
   </article>
</html>